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Background-—The role of subtle disturbances of brain perfusion in the risk of transient ischemic attack (TIA) or ischemic stroke
remains unknown. We examined the association between global brain perfusion and risk of TIA and ischemic stroke in the general
population.
Methods and Results-—Between 2005 and 2015, 5289 stroke-free participants (mean age, 64.3 years; 55.6% women) from the
Rotterdam Study underwent phase-contrast brain magnetic resonance imaging at baseline to assess global brain perfusion. These
participants were followed for incident TIA or ischemic stroke until January 1, 2016. We investigated associations between global
brain perfusion (mL of blood ﬂow/100 mL of brain/min) and risk of TIA and ischemic stroke using Cox regression models with
adjustment for age, sex, and cardiovascular risk factors. Additionally, we investigated whether associations were modiﬁed by
retinal vessel calibers, small and large vessel disease, blood pressure, and heart rate. During a median follow-up of 7.2 years
(36 103 person-years), 137 participants suffered a TIA and another 108 an ischemic stroke. We found that lower global brain
perfusion was associated with a higher risk of TIA, but not with the risk of ischemic stroke (adjusted hazard ratio, 95% CI, per
standard deviation decrease of global brain perfusion: 1.29, 1.07–1.55 for TIA and adjusted hazard ratio of 1.06, 0.87–1.30 for
ischemic stroke). Across strata of wider arteriolar retinal calibers, lower brain perfusion was more prominently associated with TIA,
but not with ischemic stroke.
Conclusions-—In a community-dwelling population, impaired global brain perfusion increased the risk of TIA, but not of ischemic
stroke. ( J Am Heart Assoc. 2019;8:e011565. DOI: 10.1161/JAHA.118.011565.)
Key Words: perfusion • population studies • prospective cohort study • stroke • transient ischemic attack
S troke is caused by insufﬁcient perfusion to speciﬁcregions of the brain, leading to neuronal dysfunction and
ultimately cell death.1 If the disruption is of short duration, it
may instead lead to a transient ischemic attack (TIA).2
Maintenance of sufﬁcient perfusion of the brain is achieved
primarily by arterioles, which either dilate or contract.3 In the
presence of cardiovascular risk factors and arteriolosclerosis,
this regulating ability of arterioles is affected and can lead to
disruptions in brain perfusion. In this light, cerebral hypoper-
fusion has been suggested as a potential link between
vascular damage and TIA and stroke and is a potential target
for preventive interventions.4,5 However, the temporal rela-
tionship between cerebral hypoperfusion and risk of TIA or
stroke remains undeﬁned. Global brain perfusion is a
hemodynamic factor, which reﬂects more-subtle and chronic
changes in brain perfusion.6 Until recently, studies assessing
global brain perfusion have only been performed in people
with previous stroke or in patients with asymptomatic or
symptomatic high-grade carotid stenosis, in which lower
global brain perfusion increased the risk of stroke.7 Yet, it is
unknown whether, in the absence of high-grade carotid
stenosis, global brain perfusion is related to occurrence of TIA
and stroke. Moreover, it is unclear whether any impact of poor
global brain perfusion on stroke risk is augmented by
additional pathology along the brain vasculature, either as
large or small vessel disease. Identifying individuals who are
at increased hemodynamic risk of stroke can be of major
importance for preventive purposes.
Against this background, we investigated the association
of global brain perfusion at baseline with the risk of TIA and
From the Departments of Epidemiology (L.F., D.B., U.M., M.L.P.P., H.I.Z,
M.W.V., M.A.I., M.K.I.), Radiology and Nuclear Medicine (D.B., M.W.V.), and
Neurology (P.J.K., M.K.I.), Erasmus MC University Medical Center, Rotterdam,
the Netherlands.
*Dr M. Arfan Ikram and Dr M. Kamran Ikram are co-senior authors.
Correspondence to: M. Kamran Ikram, MD, PhD, Department of Epidemi-
ology, Erasmus MC University Medical Center, PO Box 2040, 3000CA
Rotterdam, the Netherlands. E-mail: m.ikram@erasmusmc.nl
Received January 9, 2019; accepted February 8, 2019.
ª 2019 The Authors. Published on behalf of the American Heart Association,
Inc., by Wiley. This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivs License, which permits use
and distribution in any medium, provided the original work is properly cited,
the use is non-commercial and no modiﬁcations or adaptations are made.
DOI: 10.1161/JAHA.118.011565 Journal of the American Heart Association 1
ORIGINAL RESEARCH
D
ow
nloaded from
 http://ahajournals.org by on December 18, 2019
ischemic stroke in a large sample of community-dwelling
elderly with an average follow-up of 7 years. We hypothesized
that lower global brain perfusion is a risk factor for incident
TIA and ischemic stroke, and that this association is modiﬁed
by markers of small and large vessel disease.
Methods
Study Population
This study is embedded within the Rotterdam Study, a large,
population-based cohort study in the Netherlands that started
in 1990. The study is aimed at investigating determinants of
various chronic diseases among elderly people.8 The original
study population consisted of all residents of Ommoord, a
district in Rotterdam, aged ≥55 years. In 2000, the cohort
was expanded with another 3011 participants with the same
inclusion criteria, and in 2006, a further expansion of the
cohort was initiated in which 3932 participants were included,
aged 45 to 54 years. Follow-up examinations at the research
center are performed every 3 to 5 years. From 2005 onward,
brain magnetic resonance imaging (MRI) was implemented in
the core study protocol and all participants were invited to
undergo brain MRI.9
The Rotterdam Study has been approved by the Medical
Ethics Committee of the Erasmus MC (registration number
MEC 02.1015) and by the Dutch Ministry of Health, Welfare
and Sport (Population Screening Act WBO, license number
1071272-159521-PG). The Rotterdam Study has been
entered into the Netherlands National Trial Register (NTR;
www.trialregister.nl) and into the World Health Organization
International Clinical Trials Registry Platform (ICTRP; www.
who.int/ictrp/network/primary/en/) under shared catalog
number NTR6831. All participants provided written informed
consent to participate in the study and have their information
obtained from treating physicians. Requests to access the
data set from qualiﬁed researchers trained in human subject
conﬁdentiality protocols may be sent to the Department of
Epidemiology, Erasmus MC University Medical Center at
f.vanrooij@erasmusmc.nl.
Population for Analysis
Of 5644 people undergoing a ﬁrst MRI scan, no reliable
measure of cerebral blood ﬂow could be obtained in 5 (0.09%)
people. After excluding participants with prevalent TIA or
stroke (n=320) and 30 participants with missing follow-up
(n=30) data, 5289 participants were included for analysis.
Follow-up for TIA and stroke was complete for 93.7% of
potential person-years (Figure 1).
Assessment of Global Brain Perfusion
All participants were scanned at baseline on a 1.5-Tesla MRI
scanner (General Electric Healthcare, Milwaukee, WI) with a
dedicated 8-channel head coil. The full MRI protocol has been
described in detail before.9 Speciﬁcally, for the ﬂow mea-
surements, we performed a two-dimensional phase-contrast
sequence.10,11 A two-dimensional thick slab projection phase
contrast angiographic localizer (60 mm thick, velocity encod-
ing=60 cm/s) is positioned sagittally in order to determine
the location of the carotid and basilar arteries. Next, a thin
slice perpendicular to all 3 vessels at the level of the
precavernous internal carotid artery is positioned (velocity
encoding=120 cm/s, slice thickness 5 mm, number of exci-
tations=8). From the resulting images, we calculated cerebral
blood ﬂow using interactive data-language–based custom
software (Cinetool version 4; General Electric Healthcare).
Two independent, experienced technicians drew circular to
elliptical regions of interest manually around both carotids
and the basilar artery at the level of the clinoid segment on
the phase-contrast images, encompassing the entire lumen of
the vessel (inter-rater correlations, >0.94 for all vessels).12
For improved visualization of vessel boundaries, the contrast
between the arteries of interest and the background were
inverted. In each region of interest, the value of mean signal
intensity reﬂected the ﬂow velocity in the vessel (cm/s). By
multiplying the average velocity with the cross-sectional area
of the vessel, ﬂow (in mL/s) was calculated. To obtain global
cerebral blood ﬂow in mL/min, ﬂow rates for the carotid
Clinical Perspective
What Is New?
• Lower global brain perfusion is associated with an increased
risk of transient ischemic attack, but not of ischemic stroke,
in the general population.
• This association may be modiﬁed by wider arteriolar and
venular retinal calibers for transient ischemic attack and
elevated blood pressure for ischemic stroke.
What Are the Clinical Implications?
• Although transient ischemic attack and ischemic stroke
share many risk factors, speciﬁcally with regard to the role
of global brain perfusion, our study also suggests the
existence of speciﬁc etiological differences.
• Our ﬁndings call for further investigation of perfusion-
related differences in the pathophysiology of transient
ischemic attack and ischemic stroke, speciﬁcally in light of
compensatory mechanisms such as autoregulatory vasodi-
lation and collateral circulation, in the brain.
• More-detailed regional changes are important to take into
consideration in order to assess the potential of global brain
perfusion as a target for prevention of vascular events.
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arteries and the basilar artery were summed and multiplied by
60 s/min. We calculated global brain perfusion (in mL/min of
blood per 100 mL of brain) by dividing global cerebral blood
ﬂow (mL/min) by each individual’s brain volume (mL) and
multiplying the obtained result by 100 mL of brain volume.
Brain volume was calculated by adding up gray and white
matter volumes, converted to milliliters.
Assessment of Retinal Vessel Calibers
Retinal microvascular calibers are considered markers of
small vascular pathology, but also markers of vascular
autoregulation,13,14 which we therefore stratiﬁed for. We
assessed retinal microvascular calibers (arteriolar and venular
calibers [in lm]) using fundus photographs and the Retinal
Vessel Measurement System (Retinal Analysis; Optimate,
Madison, WI; Department of Ophthalmology and Visual
Science, University of Wisconsin-Madison, Madison, WI)15 as
previously described.16,17 Retinal microvascular calibers were
assessed in a subset of 3219 individuals.
Assessment of Small Vessel and Large Vessel
Disease
For the lacunar infarcts and white matter hyperintensity
(WMH) measurements on MRI scans, gray matter volume,
white matter volume, and cerebrospinal ﬂuid were quantiﬁed
using an automated tissue segmentation method, based on a
k-nearest-neighbour brain tissue classiﬁer algorithm.18 This
was extended with a custom-developed WMH segmenta-
tion.19 Segmentation results were visually inspected and, if
needed, corrected manually. All scans were furthermore rated
by trained research physicians, blinded to clinical data, for the
presence of lacunar infarcts (deﬁned as focal lesions ≥3 and
˂15 mm in size with the same signal characteristics as
cerebrospinal ﬂuid on all sequences, and, if located
Follow-up for TIA or stroke was complete for 
93.7% of potential person-years
Participants with prevalent TIA or stroke (n=320)
Subjects with perfusion measurements (n=5639)
Eligible and scheduled for first MRI scan 
(n=5644)
Excluded from study (n=5):
No perfusion measurement
TIA or stroke-free participants (n=5319)
Cohort I (n=3558) Cohort II (n=2506) Cohort III (n=3932)
Participants with missing follow-up time (n=30)
Study population (n=5289)
Figure 1. Flow chart of study population. MRI indicates magnetic resonance imaging; TIA, transient ischemic attack.
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supratentorially, with a hyperintense rim on the ﬂuid-
attenuated inversion recovery sequence).
Markers of large vessel disease (intima-media thickness
and carotid plaques) were measured as follows: Doppler
ultrasound was used to measure carotid stenosis (≥50%
stenosis). To measure carotid intima-media thickness and
carotid plaques, ultrasonography of the common carotid
artery, carotid bifurcation, and left and right internal carotid
artery was performed with a 7.5-MHz linear-array transducer
(ATL Ultra-Mark IV, Advanced Technology Laboratories,
Cherry Hill, NJ).20
Stroke and TIA Assessment
Deﬁnition of stroke was based on World Health Organization
criteria,21 describing a syndrome of rapidly developing
symptoms of focal or global cerebral dysfunction lasting
24 hours or longer or leading to death, with apparent
vascular cause. Prevalent stroke was assessed at baseline
during interview, and we veriﬁed these data with medical
records. After study entry, we continuously monitored
participants after enrollment for incident stroke through
linkage of the study database with ﬁles from general
practitioners. Files of nursing home physician’s and ﬁles
from general practitioners of participants who moved out of
the district were also checked. We obtained additional
information from hospital records. When potential strokes
were found, they were reviewed by research physicians and
veriﬁed by an experienced neurologist. We then categorized
strokes into ischemic or hemorrhagic on the basis of
neuroimaging reports. If neuroimaging was missing and we
could not differentiate the type of stroke according to the
symptoms, the stroke was classiﬁed as unspeciﬁed.
Subarachnoid haemorrhages attributed to ruptured aneur-
ysms were not considered stroke events. For this study, we
were mainly interested in ischemic stroke as outcome.
Follow-up for incident stroke was complete until January 1,
2016.
A similar workup was performed to determine prevalent
and incident TIA.22 Transient neurological attacks (TNAs)
were deﬁned as attacks of sudden neurological symptoms
that completely resolved within 24 hours, with no clear
evidence for the diagnosis of migraine, epilepsy, Meniere
disease, hyperventilation, cardiac syncope, hypoglycemia, or
orthostatic hypotension.23 If only focal brain symptoms
(hemiparesis, hemihypesthesia, dysphasia, dysarthria, amau-
rosis fugax, hemianopia, hemiataxia, diplopia, or vertigo)
were reported, the event was classiﬁed as a focal TNA. If
only nonfocal brain symptoms (decreased consciousness,
unconsciousness, confusion, amnesia, unsteadiness, nonro-
tatory dizziness, positive visual phenomena, cardiac or
vegetative signs, paresthesias, bilateral weakness, and
unwell feelings) were reported, the event was classiﬁed as
a nonfocal TNA. If both focal and nonfocal symptoms were
reported for the same attack, a mixed TNA was diagnosed.
For this study, we only used the focal and mixed TNAs as an
outcome for TIA.
Other Measurements in the Rotterdam Study
Information on cardiovascular risk factors was obtained by
interview, physical examination, and blood sampling.8 We
assessed history of smoking (current, former, or never) and
use of antihypertensive, lipid-lowering, and antithrombotic
medication at baseline by interview. Body mass index was
calculated as weight (kg)/length (m2). Diastolic and systolic
blood pressures were measured twice on the right arm with a
random-zero sphygmomanometer; for analyses, the mean of
these readings was used. Heart rate was measured during
sitting blood pressure measurement. Total cholesterol and
high-density lipoprotein cholesterol were measured by an
automated enzymatic procedure. Type 2 diabetes mellitus
was deﬁned as use of blood-glucose–lowering medication at
baseline or having a fasting serum glucose level of ≥126 mg/
dL or ≥7.0 mmol/L.24
Statistical Analysis
First, we investigated the association of global brain
perfusion (per SD decrease, and in tertiles) with the risk of
TIA and ischemic stroke separately and combined (whichever
came ﬁrst) using Cox proportional hazards models. In model
1, we adjusted for age, sex, and cohort. In model 2, we
additionally adjusted for smoking status, systolic and
diastolic blood pressure, blood-pressure– and lipid-lowering
medication, antithrombotic medication use, diabetes melli-
tus, body mass index, carotid stenosis, total cholesterol,
high-density lipoprotein, and MRI-deﬁned lacunar infarcts.
We censored for incident TIAs during follow-up in the
analyses on ischemic stroke and for incident stroke in the
analyses on TIA. We repeated the same analyses while not
censoring for incident TIAs during follow-up in the analyses
on stroke to compare what the effect is of brain perfusion
when having a TIA before a stroke. For all Cox models, we
tested the proportional hazard assumption using Schoenfeld
residuals.
Second, we investigated potential effect modiﬁcation by
retinal vessel calibers, small and large vessel disease, and
ﬁnally blood pressure and heart rate on the association of
brain perfusion with TIA and ischemic stroke. As markers of
small vessel disease, we considered lacunar infarcts and
WMHs. Whereas lacunar infarcts were dichotomized into yes
versus no, we stratiﬁed WMHs at their median (3.0 mL) and
retinal calibers into tertiles. Regarding the association of
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blood pressure, lacunar infarcts, and WMH with global brain
perfusion, we would like to point to the work of our colleagues
in this same sample of community-dwelling people.25,26 As
markers of large vessel disease, we considered carotid intima
media thickness and carotid plaques. Whereas we stratiﬁed
carotid intima media thickness using a cutoff of 1 mm, carotid
plaques were dichotomized into presence and absence. As
cardiovascular determinants, we chose systolic and diastolic
blood pressure and heart rate because these modify the
diameter of blood vessels. Because of potential overﬁtting of
the models, we only adjusted these analyses for age, sex, and
study cohort. In addition to these stratiﬁed analyses, we also
tested for interaction on the multiplicative scale by adding
interaction terms to the further adjusted regression models
(model 2).
Third, because we deﬁned TIA and ischemic stroke as
clinical diagnoses, we assessed the effect of brain infarction
on MRI by performing a sensitivity analysis in which we
excluded participants with the presence of cortical infarcts on
brain MRI. Finally, we excluded people with a carotid stenosis
at baseline to preclude the effect of carotid stenosis on the
association between global brain perfusion and TIA or
ischemic stroke.
Missing data on covariables (maximum 10.3%) were
imputed using 5-fold multiple imputation based on determi-
nant, outcome, and covariables with 20 iterations for each
imputation. Distribution of covariables was similar in the
imputed versus nonimputed data set.
Analyses were done using RStudio software (version
1.0.153 2009–2017 RStudio, Inc, Boston, MA).
Results
Of the 5289 stroke-free participants at baseline, mean age
was 64.3 years (SD, 10.6) with 55.6% women and a mean
global brain perfusion of 56.2 mL/min/100 mL of brain (SD,
9.7; Table 1). During a median follow-up of 7.2 years
(36 103 person-years), 137 suffered a TIA (mean global brain
perfusion, 52.7) and 137 a stroke (mean global brain
perfusion, 53.3), whichever came ﬁrst (incidence rate for
both events, 3.8 per 1000 person-years). Within the stroke
group, 108 participants developed ischemic stroke (mean
global brain perfusion, 53.4), 20 participants developed
hemorrhagic stroke, and 9 participants developed a stroke
which was not further speciﬁed. Among participants who
developed TIA, 93 participants had only focal symptoms and
44 participants had a mix of focal and nonfocal symptoms.
The majority developed a single TIA, whereas 22 participants
had multiple attacks.
We found that global brain perfusion at baseline was
associated with a higher risk of TIA (adjusted hazard ratio
[aHR], 95% CI per SD decrease: 1.30; 1.07–1.57) and not of
ischemic stroke (aHR, 1.06; 95% CI, 0.87–1.30; Table 2).
Effect estimates were higher for the risk of ischemic stroke
when not censoring for previous TIA (aHR, 1.09; 95% CI,
0.90–1.33). Results for the association for lower global
brain perfusion with risk of TIA or any stroke combined are
shown in Table 3. The proportional hazard assumption was
met for all models.
After stratifying the analyses on retinal vessel diameter,
lower global brain perfusion was associated more promi-
nently with TIA across strata of wider arteriolar and wider
venular retinal vessel calibers compared with strata of
smaller retinal vessel calibers (aHR, 2.04; 95% CI, 1.18–3.50
for arterioles and aHR, 2.30; 95% CI, 1.26–4.17 for venules
in the widest strata). For ischemic stroke, there were no
differences between strata of retinal vessels (aHR, 1.15; 95%
CI, 0.64–2.06 for arterioles and aHR, 1.07; 95% CI, 1.72–
0.79 for venules in the widest strata; Figure 2). However,
within strata of higher diastolic blood pressure, participants
had a 51% increased risk of developing an ischemic stroke
per SD decrease of global brain perfusion, with the
Table 1. Baseline Characteristics of the Study Population
Total Cohort
(N=5289)
Women 2941 (55.6)
Age, y 64.3 (10.6)
Smoking
Current 1003 (21.1)
Former 2293 (48.3)
Never 1447 (30.5)
Systolic blood pressure, mm Hg 139.4 (21.3)
Diastolic blood pressure, mm Hg 82.6 (11.0)
Use of blood-pressure–lowering medication 1787 (34.1)
Serum total cholesterol, mmol/L 5.6 (1.1)
Serum high-density lipoprotein cholesterol, mmol/L 1.5 (0.4)
Use of lipid-lowering medication 1227 (23.4)
Type 2 diabetes mellitus 506 (9.8)
Body mass index, kg/m2 27.5 (4.2)
Carotid stenosis 141 (2.7)
Use of antithrombotic medication 878 (16.7)
Presence of lacunar infarcts 325 (6.2)
Global brain perfusion, mL/min per 100 mL brain 56.2 (9.7)
N=number of participants included in study. Data presented as mean (SD) for continuous
variables and number (percentages) for categorical variables. Data represent original
data without imputed values. Number of missing values are 546 (10.3%) for smoking, 38
(0.7%) for systolic blood pressure, 38 (0.7%) for diastolic blood pressure, 42 (0.8%) for
use of blood-pressure–lowering medication, 89 (1.7%) for serum total cholesterol, 89
(1.7%) for serum high-density lipoprotein cholesterol, 42 (0.8%) for use of lipid-lowering
medication, 114 (2.2%) for type 2 diabetes mellitus, 32 (0.6%) for body mass index, 89
(1.7%) for carotid stenosis, 42 (0.8%) for use of antithrombotic medication, and 12 (0.2%)
for the presence of lacunar infarcts.
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interaction term being borderline signiﬁcant (P=0.056),
whereas higher diastolic blood pressure did not increase
the risk of TIA (P=0.444; Figure 2). For other markers of
small and large vessel disease, no signiﬁcant differences
were found across strata for the risk of TIA or ischemic
stroke (data not shown).
We found no evidence for a change in effect of brain
perfusion on TIA or ischemic stroke after exclusion of all
people with cortical infarcts (n=66) on the MRI scan (aHR,
1.31; 95% CI, 1.08–1.58 for TIA and aHR, 1.07; 95% CI, 0.87–
1.31 for ischemic stroke). Finally, after excluding people with
carotid stenosis (n=190), also no difference was found in
effect of brain perfusion on TIA or ischemic stroke (aHR, 1.24;
95% CI, 1.02–1.51 for TIA and aHR, 1.06; 95% CI, 0.86–1.31
for ischemic stroke).
Discussion
In this population-based study, we observed that lower global
brain perfusion was associated with a higher risk of TIA, but
not of ischemic stroke.
Previous studies have assessed the association between
global brain perfusion and risk of TIA or stroke among patient-
based samples.27,28 A meta-analysis showed that lower brain
perfusion is associated with increased risk of ischemic events
in patients with symptomatic or asymptomatic carotid
stenosis or occlusion.7 In this meta-analysis, the odds ratio
for stroke was 3.87 (95% CI, 1.99–7.48) and for TIA and
stroke combined 4.65 (95% CI, 2.65–8.14). Interestingly, we
found no association of lower brain perfusion with a higher
risk of stroke, even when censoring for previous TIA, which is
in contrast with these earlier clinical studies. An important
explanation for this may be the differences in study popula-
tion. All of the previous ﬁndings were based on patients with
carotid artery stenosis, whereas our study population com-
prised of asymptomatic community-dwelling elderly. A study
population comprising of patients with carotid stenosis will
have more comorbidity, thereby increasing the risk of
developing a TIA or stroke.
Surprisingly, we found that the effect of lower global brain
perfusion was more pronounced for TIA than ischemic stroke.
This implies that lower global brain perfusion is more likely a
Table 2. Global Brain Perfusion and the Risk of TIA and Ischemic Stroke
TIA Ischemic stroke
n/N
Model I Model II
n/N
Model I Model II
HR, 95% CI HR, 95% CI HR, 95% CI HR, 95% CI
Global brain perfusion
(per SD decrease)
137/5289 1.34, 1.10 to 1.62 1.30, 1.07 to 1.57 108/5289 1.09, 0.89 to 1.34 1.06, 0.87 to 1.30
Tertile 1 (19–52) 59/1716 1.83, 1.14 to 2.92 1.78, 1.11 to 2.85 49/1716 1.33, 0.81 to 2.18 1.29, 0.78 to 2.12
Tertile 2 (52–59) 51/1762 1.84, 1.15 to 2.95 1.74, 1.08 to 2.80 33/1762 1.28, 0.77 to 2.13 1.31, 0.79 to 2.18
Tertile 3 (59–154) 27/1811 1 (reference) 1 (reference) 26/1811 1 (reference) 1 (reference)
Global brain perfusion tertiles presented as lowest, middle, and highest (mL/min/100 mL). Cox regression model I: adjusted for sex, age, and study cohort. Cox regression model II: as
model I, additionally adjusted for systolic blood pressure, diastolic blood pressure, blood-pressure–lowering medication, serum total cholesterol, serum high-density lipoprotein cholesterol,
lipid-lowering medication, smoking, type 2 diabetes mellitus, body mass index, carotid stenosis, antithrombotic medication use, and silent brain infarcts (lacunar infarcts). HR indicates
hazard ratio; n, number of cases; N, number of people at risk; TIA, transient ischemic attack.
Table 3. Global Brain Perfusion and the Risk of TIA or Ischemic Stroke Combined
TIA or Ischemic Stroke
n/N
Model I Model II
HR, 95% CI HR, 95% CI
Global brain perfusion (per SD decrease) 246/5289 1.22, 1.06 to 1.40 1.18, 1.03 to 1.36
Tertile 1 (19–52) 108/1716 1.55, 1.10 to 2.17 1.49, 1.06 to 2.09
Tertile 2 (52–59) 84/1762 1.46, 1.03 to 2.05 1.45, 1.03 to 2.05
Tertile 3 (59–154) 54/1811 1 (reference) 1 (reference)
Total brain perfusion tertiles presented as lowest, middle, and highest (mL/min/100 mL). Cox regression model I: adjusted for sex, age, and study cohort. Cox regression model II: as
model I, additionally adjusted for systolic blood pressure, diastolic blood pressure, blood-pressure–lowering medication, serum total cholesterol, serum high-density lipoprotein cholesterol,
lipid-lowering medication, smoking, type 2 diabetes mellitus, body mass index, carotid stenosis, antithrombotic medication use, and silent brain infarcts (lacunar infarcts). HR indicates
hazard ratio; n, number of cases; N, number of people at risk; TIA, transient ischemic attack.
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hemodynamic risk factor for focal transient ischemia than
permanent ischemia. It is known that a reduction in global
cerebral blood ﬂow may give focal worsening of an existing
neurological deﬁcit in the brain (ie, after TIA or stroke).29
However, in people with lower global brain perfusion without
history of TIA or stroke, probably the combination of a short
disruption of global brain perfusion with impaired autoregu-
latory vasodilation leads to a TIA, whereas the presence of
cardiovascular risk factors are necessary to cause a longer
drop in global brain perfusion sufﬁcient to lead to an
ischemic stroke. An explanation could be that within an
individual, perfusion in the cerebral arteries and larger
arterioles ﬂuctuates with the cardiac cycle.30 Given a lower
mean brain perfusion, these ﬂuctuations resulting in peaks
and troughs may during a trough drop below the critical
ischemia point, causing a mild and short ischemia in the
brain and consequently a TIA, but not a stroke attributed to a
fast recovery from this trough in this brain perfusion cycle.31
Such a harmful drop in brain perfusion will especially occur
when cerebral autoregulation is poor, for example, by
impaired myogenic mechanisms.32 Indeed, in the analyses
in which we stratiﬁed by retinal vessel diameters, we found
evidence that in participants with wider retinal calibers, the
association between global brain perfusion and TIA was
stronger, but did not modify the association with ischemic
stroke (Figure 2). Myogenic autoregulation is widely dis-
tributed over vascular beds, including the retina and brain.33
Autoregulation of the retinal vessels may thus reﬂect
autoregulation in the small brain vessels. If arterioles are
already fully vasodilated, they may not be able to widen any
further in response to a drop in perfusion. Thus, our ﬁndings
of more-pronounced effects in people with widened retinal
vessels suggest exhausted vasodilatory response to be an
important contributing factor for TIA in the general popula-
tion. For ischemic stroke to occur, however, it is likely that
more is needed than a drop in global brain perfusion, namely
the presence of cardiovascular risk factors. This is supported
by our ﬁnding that participants with higher diastolic blood
pressure show an increased risk for developing ischemic
stroke per decrease of global brain perfusion. Another
possibility is that a longer drop in global brain perfusion is
needed to develop a stroke, for which a lower global brain
Figure 2. Assessment of effect measure modiﬁcation between global brain perfusion per SD decrease and various cardiovascular
determinants on the risk of TIA and ischemic stroke. Assessing effect measure modiﬁcation by stratiﬁcation and interaction terms between
global brain perfusion per SD decrease and markers of microvascular disease (arteriolar and venular retinal diameter) and cardiovascular
determinants (systolic and diastolic blood pressure and heart rate). P value indicates P value for interaction. Abbreviations: lm=micrometer;
mm Hg=millimeter of mercury; b/m=beats per minute; n=number of cases; N=number of people at risk, which may differ per stratiﬁed analyses
depending on the availability of data within the study population. Cox regression model I: adjusted for sex, age, study cohort, and when
assessing retinal vessels; the other retinal vessel was included in the model. TIA indicates transient ischemic attack.
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perfusion in the general population is not a risk factor alone.
Although TIA and ischemic stroke share many risk factors,
speciﬁcally with regard to the role of global brain perfusion,
our study also suggests the existence of speciﬁc etiological
differences. Further studies are needed to determine to
which factors the lack of effect of global brain perfusion on
ischemic stroke in the general population are attributable, for
instance, collateral circulation in the brain.
Limitations of our study include the following. First, we
used single global brain perfusion measurements in relation to
the risk of TIA or stroke. We could not perform analyses on
repeated measurements of brain perfusion, because of small
numbers at this moment. Hence, we could not assess
ﬂuctuations in perfusion or display changes of perfusion over
a longer period of time. In addition, more-advanced imaging
techniques, such as arterial spin labelling, tend to have lower
and slightly less-variable absolute perfusion measures attrib-
uted to postprocessing with a single value deconvolution
model, compared with phase-contrast imaging measures of
perfusion, where overestimation of brain perfusion can
particularly occur in aged brains because of usage of a max
slope model.34 But such a systematic deviation would not
inﬂuence obtained relative risks, and a larger variability would
only lead to dilution of effect estimates. It is important to
acknowledge that using our phase-contrast method, we
obtain a measure of blood ﬂow in major brain arteries which
is assumed to represent homogeneous ﬂow in the entire brain
under normal conditions. This directly highlights that poten-
tially interesting inhomogeneities of perfusion among different
brain regions cannot be taken into account. There may be
compensation on other brain regions, and these hypo- and
hyperperfusion regions may average out in the carotid and
basilar arterial ﬂow. Second, the vast majority of our
population is of European ancestry, limiting generalizability
to other ethnicities. More speciﬁcally, it is known that the
impact of small and large vessel disease on stroke is different
between ethnic groups, where in whites stroke is more often
associated with large vessel disease (carotid stenosis)
compared with small vessel disease (lacunar infarcts) in
Africans and Asians.35 Further study is needed to conﬁrm that
these ﬁndings indeed apply to other ethnicities and geo-
graphical regions.
Strengths of our study are the population-based setting
and the thorough assessment and follow-up for stroke and
TIA. Another strength is the amount of stroke and TIA cases,
which allowed us to investigate the association with brain
perfusion for these outcomes separately. Finally, our cohort
includes both women and men, allowing us to investigate a
heterogenic population, although we found no effect modi-
ﬁcation of the association between brain perfusion and risk
of ischemic stroke or TIA by sex in our study (data not
shown).
In conclusion, impaired global brain perfusion increases
the risk of TIA, but not of ischemic stroke, in this community-
dwelling population. These ﬁndings support a role of global
brain perfusion as a hemodynamic risk factor for developing a
TIA. Further studies are warranted to unravel mechanisms in
relation to compensatory mechanisms, such as autoregula-
tory vasodilation and collateral circulation, in the brain. Also,
more-detailed regional changes that cannot be detected by
phase-contrast imaging are important to take into consider-
ation in order to assess the potential of global brain perfusion
as a target for prevention of vascular events.
Acknowledgments
We gratefully acknowledge the study participants of the Ommoord
district and their general practitioners and pharmacists for their
devotion in contributing to the Rotterdam Study. We also thank all
staff that facilitated assessment of participants in the Rotterdam
Study throughout the years.
Author Contributions
All authors have made a substantial intellectual contribution
to conception and design of the study (M.K. Ikram, M.A.
Ikram, Portegies), acquisition of data (Koudstaal, M.K. Ikram,
Mutlu, Fani, Zonneveld, Portegies, Vernooij), analysis and
interpretation of data (Fani, Bos, M.K. Ikram, M.A. Ikram),
drafting the manuscript (Fani), or drafting a signiﬁcant portion
of the manuscript or ﬁgures (Fani, M.K. Ikram, M.A. Ikram,
Bos, Portegies). All authors approved the ﬁnal version of the
manuscript for publication. M.A. Ikram and M.K. Ikram had full
access to the data in the study and take responsibility for data
integrity and accuracy of data analysis.
Sources of Funding
This work was supported by the European Union’s Horizon
2020 Research and Innovation Programme (grant number
667375) (“CoSTREAM”); the Erasmus Medical Center and
Erasmus University Rotterdam; the Netherlands Organization
for Scientiﬁc Research (NWO) (grant numbers 948-00-010,
918-46-615); the Netherlands Organization for Health
Research and Development (ZonMw); The Research Institute
for Diseases in the Elderly (RIDE); the Ministry of Education,
Culture and Science; the Ministry of Health, Welfare and
Sports; the European Commission (DG XII); and the
Municipality of Rotterdam. The funding source had no role
in study design, collection, analysis, interpretation of data,
writing of the report or decision to submit the article for
publication.
Disclosures
None.
DOI: 10.1161/JAHA.118.011565 Journal of the American Heart Association 8
Global Brain Perfusion, TIA, and Stroke Fani et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on December 18, 2019
References
1. Brott T, Bogousslavsky J. Treatment of acute ischemic stroke. N Engl J Med.
2000;343:710–722.
2. Calanchini PR, Swanson PD, Gotshall RA, Haerer AF, Poskanzer DC, Price TR,
Conneally PM, Dyken ML, Futty DE. Cooperative study of hospital frequency
and character of transient ischemic attacks. IV. The reliability of diagnosis.
JAMA. 1977;238:2029–2033.
3. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc
Brain Metab Rev. 1990;2:161–192.
4. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW. Increased stroke
risk predicted by compromised cerebral blood ﬂow reactivity. J Neurosurg.
1993;79:483–489.
5. Reinhard M, Gerds TA, Grabiak D, Zimmermann PR, Roth M, Guschlbauer B,
Timmer J, Czosnyka M, Weiller C, Hetzel A. Cerebral dysautoregulation and the
risk of ischemic events in occlusive carotid artery disease. J Neurol.
2008;255:1182–1189.
6. Giardino ND, Friedman SD, Dager SR. Anxiety, respiration, and cerebral blood
ﬂow: implications for functional brain imaging. Compr Psychiatry.
2007;48:103–112.
7. Gupta A, Chazen JL, Hartman M, Delgado D, Anumula N, Shao H, Mazumdar M,
Segal AZ, Kamel H, Leifer D, Sanelli PC. Cerebrovascular reserve and stroke
risk in patients with carotid stenosis or occlusion: a systematic review and
meta-analysis. Stroke. 2012;43:2884–2891.
8. Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH,
Goedegebure A, Klaver CCW, Nijsten TEC, Peeters RP, Stricker BH, Tiemeier
H, Uitterlinden AG, Vernooij MW, Hofman A. The Rotterdam Study: 2018
update on objectives, design and main results. Eur J Epidemiol.
2017;32:807–850.
9. Ikram MA, van der Lugt A, Niessen WJ, Koudstaal PJ, Krestin GP, Hofman A,
Bos D, Vernooij MW. The Rotterdam Scan Study: design update 2016 and
main ﬁndings. Eur J Epidemiol. 2015;30:1299–1315.
10. Buijs PC, Krabbe-Hartkamp MJ, Bakker CJ, de Lange EE, Ramos LM, Breteler
MM, Mali WP. Effect of age on cerebral blood ﬂow: measurement with ungated
two-dimensional phase-contrast MR angiography in 250 adults. Radiology.
1998;209:667–674.
11. Spilt A, Van den Boom R, Kamper AM, Blauw GJ, Bollen EL, van Buchem MA.
MR assessment of cerebral vascular response: a comparison of two methods.
J Magn Reson Imaging. 2002;16:610–616.
12. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Vrooman HA, Hofman
A, Krestin GP, Breteler MM. Total cerebral blood ﬂow and total brain perfusion
in the general population: the Rotterdam Scan Study. J Cereb Blood Flow
Metab. 2008;28:412–419.
13. Ikram MK, De Jong FJ, Van Dijk EJ, Prins ND, Hofman A, Breteler MM, De Jong
PT. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam
Scan Study. Brain. 2006;129:182–188.
14. Robinson F, Riva CE, Grunwald JE, Petrig BL, Sinclair SH. Retinal blood ﬂow
autoregulation in response to an acute increase in blood pressure. Invest
Ophthalmol Vis Sci. 1986;27:722–726.
15. Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, Sharrett AR,
Davis MD, Cai J. Methods for evaluation of retinal microvascular abnormalities
associated with hypertension/sclerosis in the Atherosclerosis Risk in
Communities Study. Ophthalmology. 1999;106:2269–2280.
16. Mutlu U, Ikram MK, Wolters FJ, Hofman A, Klaver CC, Ikram MA. Retinal
microvasculature is associated with long-term survival in the general adult
Dutch population. Hypertension. 2016;67:281–287.
17. Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE. Revised
formulas for summarizing retinal vessel diameters. Curr Eye Res.
2003;27:143–149.
18. Vrooman HA, Cocosco CA, van der Lijn F, Stokking R, Ikram MA, Vernooij MW,
Breteler MM, Niessen WJ. Multi-spectral brain tissue segmentation using
automatically trained k-Nearest-Neighbor classiﬁcation. Neuroimage.
2007;37:71–81.
19. de Boer R, Vrooman HA, van der Lijn F, Vernooij MW, Ikram MA, van der Lugt
A, Breteler MM, Niessen WJ. White matter lesion extension to automatic brain
tissue segmentation on MRI. Neuroimage. 2009;45:1151–1161.
20. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid
intima-media thickness and risk of stroke and myocardial infarction: the
Rotterdam Study. Circulation. 1997;96:1432–1437.
21. Hatano S. Experience from a multicentre stroke register: a preliminary report.
Bull World Health Organ. 1976;54:541–553.
22. Bos MJ, van Rijn MJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM.
Incidence and prognosis of transient neurological attacks. JAMA.
2007;298:2877–2885.
23. Kim JS. Symptoms of transient ischemic attack. Front Neurol Neurosci.
2014;33:82–102.
24. Ligthart S, van Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, van
Hoek M, Sijbrands EJ, Franco OH, Dehghan A. Lifetime risk of developing
impaired glucose metabolism and eventual progression from prediabetes to
type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol.
2016;4:44–51.
25. Wolters FJ, Zonneveld HI, Hofman A, van der Lugt A, Koudstaal PJ, Vernooij
MW, Ikram MA; Heart-Brain Connection Collaborative Research Group.
Cerebral perfusion and the risk of dementia: a population-based study.
Circulation. 2017;136:719–728.
26. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM;
Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase
stroke risk in the general population: the Rotterdam Scan Study. Stroke.
2003;34:1126–1129.
27. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Nakamura K, Yamamoto
Y, Yonekura Y, Konishi J, Kimura J. Evidence of misery perfusion and risk for
recurrent stroke in major cerebral arterial occlusive diseases from PET. J
Neurol Neurosurg Psychiatry. 1996;61:18–25.
28. Dubow JS, Salamon E, Greenberg E, Patsalides A. Mechanism of acute
ischemic stroke in patients with severe middle cerebral artery atherosclerotic
disease. J Stroke Cerebrovasc Dis. 2014;23:1191–1194.
29. Powers WJ, Videen TO, Diringer MN, Aiyagari V, Zazulia AR. Autoregulation
after ischaemic stroke. J Hypertens. 2009;27:2218–2222.
30. Newell DW, Aaslid R, Stooss R, Reulen HJ. The relationship of blood ﬂow
velocity ﬂuctuations to intracranial pressure B waves. J Neurosurg.
1992;76:415–421.
31. Rickards CA, Tzeng YC. Arterial pressure and cerebral blood ﬂow variability:
friend or foe? A review. Front Physiol. 2014;5:120.
32. Schytz HW, Hansson A, Phillip D, Selb J, Boas DA, Iversen HK, Ashina M.
Spontaneous low-frequency oscillations in cerebral vessels: applications in
carotid artery disease and ischemic stroke. J Stroke Cerebrovasc Dis.
2010;19:465–474.
33. Davis MJ. Perspective: physiological role(s) of the vascular myogenic response.
Microcirculation. 2012;19:99–114.
34. Dolui S, Wang Z, Wang DJ, Mattay R, Finkel M, Elliott M, Desiderio L,
Inglis B, Mueller B, Stafford RB, Launer LJ, Jacobs DR Jr, Bryan RN, Detre
JA. Comparison of non-invasive MRI measurements of cerebral blood ﬂow
in a large multisite cohort. J Cereb Blood Flow Metab. 2016;36:1244–
1256.
35. Wolma J, Nederkoorn PJ, Goossens A, Vergouwen MD, van Schaik IN,
Vermeulen M. Ethnicity a risk factor? The relation between ethnicity and large-
and small-vessel disease in White people, Black people, and Asians within a
hospital-based population. Eur J Neurol. 2009;16:522–527.
DOI: 10.1161/JAHA.118.011565 Journal of the American Heart Association 9
Global Brain Perfusion, TIA, and Stroke Fani et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on December 18, 2019
